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Introduction
In the future, the number and duration of manned spaceflights will inexorably increase. Space agencies plan to send astronauts to the moon, asteroids and mars, whereas private companies are developing a commercial exploitation of space travel by proposing future services such as 'space taxis' and space tourism. In this context, the effect of microgravity on human physiology needs to be understood better. In addition to the well-known loss of skeletal muscle and bone mass (Hargens & Vico, 2016) , recent findings highlighted that microgravity affects iron metabolism (Zwart et al. 2013) .
Iron plays a key role in numerous biological functions, including oxygen transport, enzyme activity and energy production. The human body contains 3-5 g of iron, with 65-75% being linked to haemoglobin, 10-20% stored in the liver, associated with the iron-storage protein ferritin, 10% found in myoglobin of striated muscles (Zhang, 2010) and the remainder localized in the different cell types. Humans exposed to microgravity exhibit a decrease of the circulating levels of iron and transferrin (Smith et al. 2005; Zwart et al. 2013) . Additionally, an increase in iron storage has been reported in astronauts of the International Space Station (Zwart et al. 2013) . These findings raise concern because excess iron in tissues can impair bone and muscle metabolism, disrupt immune function and increase the sensitivity to radiation injury (Reardon & Allen, 2009; Tsay et al. 2010) . In contrast, a reduction in circulating iron may promote anaemia, a deleterious effect already observed during space missions and known as 'spaceflight anaemia' (Tavassoli, 1982) . This phenomenon could limit the duration of space travel. Although the effects of microgravity on iron metabolism have been identified, the molecular mechanism driving such regulation remains unexplored.
Iron metabolism is mainly controlled by hepcidin, a peptide hormone secreted by the liver that reduces iron export through degradation of the iron exporter, ferroportin (Zhang, 2010) . In addition, hepcidin reduces iron absorption by the duodenal enterocytes. Consequently, high levels of hepcidin induce both a decrease of serum iron and an increase of iron storage in cells expressing ferroportin, especially macrophages (Ganz, 2011) .
From these data, we hypothesized that alteration of iron metabolism parameters during microgravity could be linked to hepatic hepcidin overexpression induced by iron-related and/or inflammatory signals. To test this hypothesis, we submitted rats to hindlimb unloading (HU), the reference model to simulate the effects of microgravity in rodents (Globus & Morey-Holton, 2016) , and we analysed whether hepatic hepcidin expression and the related signal transduction pathways are modulated.
Methods

Ethical approval
The protocol and procedure used in this study were in accordance with the local committee on Ethics in Research of Rennes (authorization 01259.03) and approved by the French Ministry of Higher Education.
Animals and experimental procedures
Male Wistar rats (10 weeks old; Janvier Labs, Le Genest St Isle, France) were randomly assigned to two groups: non-suspended (control, n = 8) and hindlimb unloaded (HU, n = 8) for 7 days. Hindlimb unloading was performed by using Morey's tail-suspension model (Morey-Holton & Globus, 2002) . Rats were housed with food and water ad libitum. At the end of the protocol, rats were deeply anaesthetized with an I.P. injection of ketamine (100 mg kg −1 ) and xylazine (20 mg kg −1 ). Liver, spleen and gastrocnemius were harvested, weighed, frozen in liquid nitrogen and stored at −80°C. Blood was collected from the vena cava and the animals were killed by exsanguination. Haemoglobin concentrations were determined using HemoCue R 201+ system (HemoCue, AB, Meaux, France). Blood was centrifuged at 1500g for 10 min, after which serum was removed and stored at −80°C.
Biochemical methods
Serum iron and unsaturated iron-binding capacity (UIBC) were measured in the biochemistry laboratory (Rennes Pontchaillou Hospital) on Cobas 8000 analyser Roche R (Cobas R reagents 03183696 122 and 04536355 190, respectively, Roche Diagnostics, Meylan, France).
Serum transferrin saturation was calculated as [serum iron/(serum iron + UIBC)] × 100. Liver and spleen iron concentrations were quantified as previously described (Barry & Sherlock, 1971) . Serum interleukin-6 (IL-6) concentrations were determined using a rat IL-6 detection kit according to the manufacturer's protocol (BioLegend, San Diego, CA, USA).
Histological analysis
Spleen and liver samples were fixed in 4% paraformaldehyde fixative for 24 h and paraffin embedded. Serial transverse sections 4 μm thick were obtained from each sample using a Leica microtome and were mounted on glass slides. To visualize ferric iron deposits, deparaffinized tissue sections were stained with Perls' Prussian Blue.
RNA extraction and quantitative real-time PCR
RNA extraction and quantitative real-time PCR were performed as previously described (Pierre et al. 2013) . Analysis was done using the 2 − CT method with HPRT (liver and spleen) or RPL19 (gastrocnemius) as a reference gene. The following primer sequences were used: IL-6 (forward TCCGCAAGAGACTTCCAGC and reverse GTCTGTTGTGGGTGGTATCCTCT); hepcidin (forward CTGCAGCCTTGGCATGG and reverse CAGCAGCGCA CTGTCATCA); haptoglobin (forward AACACTTGGTT CGTTATCGCTG and reverse CCACACACTGCCTCAC ACTTG); HPRT (forward CTGATTATGGACAGGACTG AAAGAC and reverse CCAGCAGGTCAGCAAAGAACT); and RPL19 (forward CAATGCCAACTCTCGTCAACAG and reverse CATCCAGGTCACCTTCTCGG).
Western blotting
Protein extraction and Western blots were performed as previously described (Salaun et al. 2016 
Statistical analysis
Normality and equality of variances were checked using a Kolmogorov-Smirnov and Fisher test, respectively. If one of these two tests failed, we checked the significance using a Mann-Whitney U test and data were presented with a box plot. When normality and equal variance were met, we used Student's unpaired t test and data were presented as the mean ± SD. The level of significance was set at P < 0.05.
Results
Hindlimb unloading induces iron misdistribution
Initially, we aimed to check the disruption of iron metabolism induced by our model of microgravity. We found that available iron was reduced in HU rats as shown by the decrease of serum iron concentration (−35%, P = 0.002) and transferrin saturation (−25%, P = 0.011; Fig. 1A and B) . This reduction of systemic iron was not associated with changes in haemoglobin concentration (15.8 ± 0.4 versus 16.6 ± 0.30 g dl −1 , P = 0.153; Fig. 1C ). To characterize the effect of HU on iron metabolism better, we measured iron concentration in liver and spleen, the main organs responsible for iron storage. Iron content increased in the spleen of HU animals (+78%, P = 0.030; Fig. 1E ), whereas liver iron concentration was not significantly modified (P = 0.217; Fig. 1D ). These results were supported by histological analyses, where iron deposits were more visible in the spleen of HU animals ( Fig. 1F) . It is noteworthy that spleen weight was not reduced in HU conditions [0.25 ± 0.04 versus 0.23 ± 0.03 g (100 g body weight)
−1 , P = 0.437; Table 1 ], thus dismissing an increase of spleen iron concentration related to a modification of spleen weight. Taken together, our results indicate that simulated microgravity induces an increase of iron storage in the spleen associated with a reduction of the circulating iron.
Hindlimb unloading upregulates hepatic hepcidin expression via the IL-6/STAT3 signalling pathway
To investigate the mechanism by which HU induces iron misdistribution, we measured in liver the expression of hepcidin, the master regulator of iron metabolism. We found that HU increased the hepcidin mRNA level (+74%, P = 0.001, Fig. 2A ), thereby supporting a role of this hormone in the alteration of iron homeostasis observed in our experiment. Hepcidin expression is known to be upregulated by BMP6/SMAD, ERK1/2 and IL-6 /STAT3 signalling pathways (Zhao et al. 2013) . Therefore, we investigated whether these three signalling pathways were activated in the liver of HU animals. We observed that HU increased STAT3 phosphorylation state (+193%, P < 0.001; Fig. 2C and F) , whereas HU modulated neither phospho-ERK1-2 nor phospho-SMAD1/5/8 levels (Fig. 2C, D and E) . STAT3 is a transcription factor well known to regulate genes of the acute phase response, such as haptoglobin (Alonzi et al. 2001) . Herein, we observed an elevation of the mRNA level of haptoglobin (+167%, P < 0.001; Fig. 2B ) in the liver of HU rats. Taken together, these results support the suggestion that HU induces STAT3 pathway activation in the liver. Consequently, we propose that stimulated microgravity promotes a transcriptional regulation of hepcidin through the IL-6/STAT3 signalling pathway.
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Interleukin-6 mRNA increases in skeletal muscle of HU rats
Given that IL-6 is the main activator of STAT3, we analysed its mRNA level in liver, spleen and gastrocnemius. We found that IL-6 mRNA level increased in gastrocnemius of HU animals (+135%, P = 0.028; Fig. 3C ), whereas this was not the case in spleen (P = 0.444; Fig. 3B ) and liver (P = 0.657; Fig. 3A) . The increase of IL-6 mRNA in gastrocnemius was probably related to the atrophic process. Indeed, HU rats exhibited a 12% (P = 0.004; Table 1 ) loss of gastrocnemius mass, a deleterious effect well known to be associated with inflammation. The serum concentration of IL-6 remained below the limit of sensitivity of the assay in both control and HU animals.
Discussion
By using the HU model, we demonstrated that simulated microgravity induces upregulation of hepcidin, the master regulator of iron metabolism. This finding highlights that hepcidin could play a key role in the alteration of iron metabolism induced by microgravity. Furthermore, our data support the idea that HU induced hepcidin upregulation through the inflammatory signalling pathway IL-6/STAT3. This study constitutes a first step towards a better understanding of the mechanism by which microgravity alters iron metabolism.
The HU model has been widely used for decades to understand the effects of microgravity observed during spaceflight. This model presents the advantage of exploring the organ-specific responses to microgravity, a key characteristic of the spaceflight environment, and excludes the concomitant effects of the astronaut's exposure to radiation or hyperoxia. The neuroendocrine stress occurring during the first few days, depending on the experiment, is the main weakness recognized for the HU model, because it could mask or amplify adaptive responses to microgravity (Globus & Morey-Holton, 2016) . However, as highlighted by Globus & Morey-Holton (2016) , this acute stress in rodents may mimic the acute stress occurring in astronaut crews during launch and the first days of spaceflight (Stowe et al. 2011; Mehta et al. 2014) .
As observed during space missions, microgravity reduces the serum iron concentration and increases iron storage in humans (Smith et al. 2005) . Our model of microgravity, HU, reproduces those effects and constitutes de facto an appropriate experimental design to study the effect of spaceflight on iron metabolism. In E, spleen iron concentration. F, histological detection of iron deposits in liver and spleen sections by Perls' iron staining. Significance was checked using the Mann-Whitney U test (A and B) or Student's unpaired t test (C-E). * P < 0.05, * * P < 0.01. Values are means ± SD. Significance was checked using Student's unpaired t test. * * P < 0.01, * * * P < 0.001.
our experiment, we found that simulated microgravity increased iron storage in the spleen and reduced iron availability, as shown by the reduction of circulating iron and transferrin saturation. In other words, the increase of iron storage by HU occurred to the detriment of the blood iron content, a change that looks like an effect of hepcidin. Indeed, this hormone promotes a reduction of the circulating iron through induction of iron sequestration in cells expressing ferroportin, such as the spleen resident macrophages (Zhao et al. 2013) . Remarkably, we observed such an effect in HU rats, and this was associated with an increase of the hepcidin mRNA level. Although this result does not definitively prove a causal link between hepcidin upregulation and iron misdistribution, it supports a potential role of this hormone in the alteration of iron metabolism induced by microgravity. However, one study reported that, despite a clear alteration of iron metabolism, astronauts did not exhibit any change of the circulating level of hepcidin (Zwart et al. 2013) . Various confounding factors related to space travel, including a disturbance of circadian rhythms (Schaap et al. 2013) and hyperoxia, as well as the low number of subjects, could explain the lack of significant differences reported in this study (Zwart et al. 2013) . Alternatively, we cannot exclude the possibility that HU and microgravity alone exert a distinct effect on hepcidin production. To go further in the understanding of hepcidin regulation by microgravity, we investigated the signalling pathways modulating hepcidin expression. The BMP/SMAD signalling pathway is the main positive regulator of hepcidin (Zhao et al. 2013) . More specifically, it has been demonstrated that an increase in both transferrin saturation and liver iron content promotes BMP/SMAD activation (Core et al. 2014) . Here, we showed that hepatic phospho-SMAD1/5/8 levels were not affected by HU, whereas serum transferrin saturation was decreased and liver iron content was unchanged. Thus, our data did not support an implication of the BMP/SMAD axis in HU-induced hepcidin upregulation. In addition to the BMP/SMAD pathway, evidence from in vitro studies and Tfr2/Hfe null mice supports the view that the ERK1/2 signalling pathway is a positive regulator of hepcidin (Ramey et al. 2009; Poli et al. 2010) . Here, we observed that 7 days of HU did not affect phospho-ERK1/2 levels, thus showing that the ERK1/2 signalling pathway is not involved in HU-induced hepcidin upregulation. Finally, we explored the IL-6/STAT3 signalling pathway known to be regulated by inflammation (Zhao et al. 2013) . Interestingly, we observed that HU increased the phosphorylation state of STAT3 and the mRNA level of haptoglobin, a STAT3-inducible gene. All together, these data indicate that HU probably stimulates hepcidin synthesis through STAT3 activation.
The inflammatory cytokine IL-6 is well known to activate STAT3, which in turn promotes hepcidin production (Wrighting & Andrews, 2006) . Given that IL-6 is a well-known myokine released by atrophied muscle, we analysed its mRNA level in gastrocnemius. In agreement with others (Caron et al. 2009; Kwon et al. 2015) , we found that the IL-6 mRNA level increased in the gastrocnemius of HU animals. As HU rats exhibited a 12% loss of gastrocnemius mass, HU-induced IL-6 upregulation is most probably related to inflammation associated with the atrophic process. Indeed, atrophied myotubes produce IL-6, an effect which is mediated by the nuclear factor-κB inflammatory pathway (Yamaki et al. 2012) . Moreover, researchers in our laboratory and other studies have demonstrated that the nuclear factor-κB signalling pathway was activated early in skeletal muscle from unloaded rats (Judge et al. 2007; Salaun et al. 2016) .
Although we showed an increase of the mRNA level of IL-6 in the gastrocnemius of HU rats, we were not able to detect IL-6 in the blood. Unfortunately, serum IL-6 levels remained undetectable in both control and HU animals. This sensitive issue is frequently observed for IL-6 owing to the moderate inflammation induced by microgravity (Xu et al. 2013; Crucian et al. 2014) . The minimal detectable level of IL-6 with the ELISA kits, including those used in this study, is generally between 5 and 10 pg ml −1 , whereas in vitro studies have demonstrated in hepatocytes that small amounts of IL-6 (<2 pg ml −1 ) were able to induce a 30-fold increase of the hepcidin mRNA level (Memoli et al. 2010) . In our study, the impossibility of detecting the circulating level of IL-6 does not mean that this cytokine has no role on hepcidin expression. Dedicated studies are needed to determine the implication of IL-6 in HU-induced hepcidin upregulation.
The alteration of iron metabolism induced by microgravity raises concern because iron accumulation in tissues could promote oxidative damage through the Fenton reaction. It has been proposed that such a mechanism could accelerate loss of bone mass in astronauts, a population already exposed to a higher degree of oxidative damage because of cosmic radiation (Zwart et al. 2013) . In view of our results, the role of hepcidin in microgravity-induced oxidative damage needs to be investigated. In contrast, our results suggest that hepcidin could contribute to 'spaceflight anaemia' . Indeed, the reduction of available iron observed in HU rats could reduce erythropoiesis. In the present study, we did not report differences in haemoglobin concentration between control and HU animals. This result is in accordance with previous studies showing that microgravity did not reduce haemoglobin concentration; it decreases red blood cell mass and plasma volume, thus maintaining haemoglobin concentration (Tavassoli, 1982) . Consequently, appropriate markers are needed to study spaceflight anaemia; this was not the goal of the present study.
In humans, microgravity is simulated through bedrest, a situation which also alters iron metabolism (Zwart et al. 2009b) . Studies have shown that bedrest induces Interleukin-6 mRNA levels were measured in liver (A), spleen (B) and gastrocnemius (C). Significance was checked using the Mann-Whitney U test. * P < 0.05. a reduction of the circulating concentration of transferrin (Zwart et al. 2009a,b; Morgan et al. 2012) . In a similar manner to HU, bedrest is an immobilization model where skeletal muscle wasting occurs rapidly. This atrophic process is associated with an elevation of the circulating level of IL-6 (Bosutti et al. 2008; Mutin-Carnino et al. 2014) . As already mentioned, this cytokine stimulates the production of hepcidin and could therefore alter iron metabolism. To the best of our knowledge, no studies have measured hepcidin in bedridden patients. As a consequence, it is unknown whether hepcidin contributes to the alteration in iron metabolism observed in bedridden patients. In future studies, particular attention must be paid to hepcidin in bedridden patients; inappropriate modulation of hepcidin could have multiple deleterious effects, such as oxidative stress and anaemia. In summary, similar to spaceflight, we found that HU induces an increase of iron storage in the spleen and a decrease of circulating iron. Given that these results are associated with an elevation of hepcidin in the liver of HU animals, we propose that hepcidin could be involved in the effects of microgravity on iron metabolism. Furthermore, we show that the IL-6/STAT3 signalling pathway seems responsible for HU-induced upregulation of hepcidin. This study provides new directions to investigate the mechanism by which microgravity alters iron metabolism.
